We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
+17.96%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$4.51B
AUM Growth
+$918M
Cap. Flow
+$361M
Cap. Flow %
8.01%
Top 10 Hldgs %
46.1%
Holding
67
New
17
Increased
11
Reduced
16
Closed
8

Top Buys

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$141M
2
SNAP icon
Snap
SNAP
+$116M
3
IBM icon
IBM
IBM
+$101M
4
VTRS icon
Viatris
VTRS
+$98.5M
5
PODD icon
Insulet
PODD
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 23.92%
2 Healthcare 22.32%
3 Materials 13.96%
4 Energy 10.91%
5 Industrials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIVN icon
51
Rivian
RIVN
$23.6B
$5.42M 0.12%
231,000
AL
52
DELISTED
Air Lease Corp
AL
$4.28M 0.1%
+102,000
New +$3.86M
ENPH icon
53
Enphase Energy
ENPH
$4.62B
$3.73M 0.08%
+28,200
New +$2.99M
CYCN icon
54
Cyclerion Therapeutics
CYCN
$15.2M
$1.2M 0.03%
357,880
PLG
55
Platinum Group Metals
PLG
$160M
$1.03M 0.02%
900,000
AUROW
56
Aurora Innovation Warrant
AUROW
$317M
$214K ﹤0.01%
437,500
NEXI
57
DELISTED
NexImmune, Inc. Common Stock
NEXI
$82.1K ﹤0.01%
36,999
-1
-0% -$3
BLUA.WS
58
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$7.94K ﹤0.01%
200,000
HIPO.WS
59
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$7K ﹤0.01%
350,000
APLS
60
DELISTED
Apellis Pharmaceuticals
APLS
-2,068,000
Closed -$78.7M
EQT icon
61
EQT Corp
EQT
$32.9B
-223,958
Closed -$9.09M
FERG icon
62
Ferguson
FERG
$43.9B
-169,000
Closed -$27.8M
OPEN icon
63
Opendoor
OPEN
$3.54B
-9,930,117
Closed -$25.4M
EXE
64
Expand Energy Corp
EXE
$22.1B
-1,145,180
Closed -$98.7M
BHIL.WS
65
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
-250,000
Closed -$8.25K
FTCH
66
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-5,023,000
Closed -$10.5M
WE
67
DELISTED
WeWork Inc.
WE
-21,942
Closed -$66K

Similar funds

Slate Path Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Slate Path Capital held 67 positions worth $4.51B, up 26% from $3.59B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Slate Path Capital deployed $361M of net new capital in Q4 2023, opening 17 new positions and adding to 11 existing holdings. Its largest new stake was Hewlett Packard: 8,626,000 shares worth $146M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was US Steel, an estimated $170M trimmed.

  • Slate Path Capital's largest Q4 2023 buy was Hewlett Packard: 8,626,000 shares worth $146M.
  • Slate Path Capital added most to Viatris in Q4 2023, an estimated $98.5M increase.
  • Slate Path Capital's biggest Q4 2023 reduction was US Steel, cutting an estimated $170M.
  • Slate Path Capital fully exited Expand Energy Corp in Q4 2023, selling an estimated $98.7M.
  • Slate Path Capital's ten largest holdings make up 46% of its $4.51B portfolio in Q4 2023.
  • Slate Path Capital opened 17 new positions and closed 8 in Q4 2023.
  • Slate Path Capital's portfolio value rose 26% quarter-over-quarter to $4.51B.

Based on Slate Path Capital's 13F filing for Q4 2023, filed 14 Feb 2024.